Simple multiplex PCR for the simultaneous detection of the C282Y and H63D hemochromatosis (HFE) gene mutations

Clinical Chemistry

Volumn 45, Issue 3, 1999, Pages 426-428

  Stott, Marion K ^a   Fellowes, Andrew P ^a   Upton, Jeff D ^a   Burt, Michael J ^a   George, Peter M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; DIAGNOSTIC VALUE; GENE ISOLATION; HEMOCHROMATOSIS; HUMAN; HUMAN CELL; IRON ABSORPTION; IRON METABOLISM; POLYMERASE CHAIN REACTION;

EID: 0032914223     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.3.426     Document Type: Article

References (14)

1. 1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
2. 2. Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990;74:525-30.
3. 3. Baer DM, Simons JL, Staples RL, Rumore GJ, Morton CJ. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995;98:464-8.
4. 4. Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubu R. et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology 1997;25:1439-46.
5. 5. Burt MJ, Upton JD, Morison IM, Chapman BA, Faed JM, George PM. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis. NZ Med J 1997;110:429-32.
6. 6. Olsson KS, Eriksson K, Ritter B, Heedman PA. Screening for iron overload using transferrin saturation. Acta Med Scand 1984;215:105-12.
7. 7. Burt MJ, George DK, Powell LW. Haemochromatosis - a clinical update. Med J Aust 1996;164:348-51.
8. 8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary heamochromatosis. Nat Genet 1996;13:399-408.
9. 9. Lebron JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998;93:111-23.
10. 10. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 1998;95: 1472-7.
11. 11. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34:275-8.
12. 12. Burt MJ, George PM, Upton JD, Collett JA, Frampton CMA, Chapman TM, et al. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998;43:830-6.
13. 13. Lynas C. A cheaper and more rapid polymerase chain reaction-restriction fragment length polymorphism method for the detection of the HLA-H gene mutations occurring in hereditary hemochromatosis [Letter]. Blood 1997; 90:4235-6.
14. 14. Talmud P, Tybjaerg-Hansen A, Bhatnagar D, Mbewu A, Miller JP, Durrington P, et al. Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemia. Atherosclerosis 1991;89: 137-41.